These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Magnesium valproate-induced pedal edema on chronic therapy: A rare adverse drug reaction. Prajapati H; Kansal D; Negi R Indian J Pharmacol; 2017; 49(5):399-400. PubMed ID: 29515282 [TBL] [Abstract][Full Text] [Related]
3. Sodium Valproate-Induced Bilateral Pitting Pedal Edema - A Case Report. Panchal R; Chaudhary D; Anovadiya A Curr Drug Saf; 2018; 13(2):128-130. PubMed ID: 28782477 [TBL] [Abstract][Full Text] [Related]
4. [Severe oedema after valproate and valpromide]. Galland MC; Nguyen N; Alla P; Ruiz JM; Rodor F; Valli M Therapie; 2002; 57(2):194-6. PubMed ID: 12185971 [No Abstract] [Full Text] [Related]
5. Edema associated with valproate therapy. Basel-Vanagaite L; Zeharia A; Amir J; Mimouni M Ann Pharmacother; 1999 Dec; 33(12):1370-1. PubMed ID: 10630841 [No Abstract] [Full Text] [Related]
6. Valproate-related peripheral oedema: a manageable but probably neglected condition. Lin ST; Chen CS; Yen CF; Tsei JH; Wang SY Int J Neuropsychopharmacol; 2009 Aug; 12(7):991-3. PubMed ID: 19490736 [TBL] [Abstract][Full Text] [Related]
10. Sodium valproate and oedema. Buchanan N; Hayden M Med J Aust; 1992 Jan; 156(1):68. PubMed ID: 1734201 [No Abstract] [Full Text] [Related]
11. Conversion from delayed-release sodium valproate to extended-release sodium valproate: initial results and long-term follow-up. McCabe PH; Michel NC; McNew CD; Lehman EB Epilepsy Behav; 2006 May; 8(3):601-5. PubMed ID: 16678766 [TBL] [Abstract][Full Text] [Related]
12. Fatal liver failure associated with valproate therapy in a patient with Friedreich's disease: review of valproate hepatotoxicity in adults. König SA; Schenk M; Sick C; Holm E; Heubner C; Weiss A; König I; Hehlmann R Epilepsia; 1999 Jul; 40(7):1036-40. PubMed ID: 10403231 [TBL] [Abstract][Full Text] [Related]
13. [Lower limb edema during valpromide treatment: case report and literature review]. Gabriel L; Darcissac C; Goutelle S; Sève P; Vial T; de La Gastine B Rev Med Interne; 2015 Oct; 36(10):698-700. PubMed ID: 25544148 [TBL] [Abstract][Full Text] [Related]
14. Adding valproate to lamotrigine: a study of their pharmacokinetic interaction. Kanner AM; Frey M Neurology; 2000 Aug; 55(4):588-91. PubMed ID: 10953201 [TBL] [Abstract][Full Text] [Related]
15. Valproic acid-induced encephalopathy in very long course treated patients. Rousseau MC; Montana M; Villano P; Catala A; Blaya J; Valkov M; Allouard Y; Bugni E Brain Inj; 2009 Nov; 23(12):981-4. PubMed ID: 19831495 [TBL] [Abstract][Full Text] [Related]
16. Pedal edema associated with addition of low-dose quetiapine to valproate treatment in bipolar disorder. Chen CY; Yeh YW; Kuo SC; Shiah IS; Liu PY; Chen CL Prog Neuropsychopharmacol Biol Psychiatry; 2009 Nov; 33(8):1551-2. PubMed ID: 19665043 [No Abstract] [Full Text] [Related]
17. Valproate-induced Periorbital Edema. Hatahet S; Khalaf K; Elhamamsy S R I Med J (2013); 2021 Dec; 104(10):10-11. PubMed ID: 34846373 [TBL] [Abstract][Full Text] [Related]
19. Clinical and pharmacokinetic observations on valproate: a 3 year follow-up study in 100 children with generalized epilepsy. Steinborn B; Galas-Zgorzalewicz B Funct Neurol; 1993; 8(6):415-22. PubMed ID: 8150320 [TBL] [Abstract][Full Text] [Related]
20. [Hyperammonemia in valproate therapy in children and adolescents]. Laub MC Nervenarzt; 1986 May; 57(5):314-8. PubMed ID: 3088461 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]